Salvatore Provenzano

Author

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

Alessandra Gennari, Corrado Ficorella, Daniele Generali, Mark Bower, Nadia Harbeck, S Provenzano, S. Provenzano, Salvatore C. Provenzano, Salvatore Provenzano, Vittoria Fotia

104

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Ca' Foncello Hospital Istituti di Ricovero e Cura a Carattere Scientifico University of Palermo Università Campus Bio-Medico

About

Salvatore Provenzano is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	326
2	Pathology	8	8	298
3	Allergy	1	1	21
4	Immunology	1	1	21
5	Pharmacology	1	1	37

Salvatore Provenzano

Publications

754

Citations

H-Index

Page 1

	Year	Citations
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas) Roberta Sanfilippo, Robin L. Jones, Jean‐Yves Blay, Clinical Cancer Research	2019	113
Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients Giacomo Giulio Baldi, Silvia Stacchiotti, Valentina Mauro, Clinical Sarcoma Research	2013	103
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma Silvia Stacchiotti, Olivier Mir, Axel Le Cesne, The Oncologist	2017	84
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database Silvia Stacchiotti, Salvatore Provenzano, Gian Paolo Dagrada, Annals of Surgical Oncology Retrospective Case-series AnalysisUrologyTumoral PathologyAdvanced Epithelioid HemangioendotheliomaMedicine	2016	73
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour Silvia Stacchiotti, Monica Tortoreto, Giacomo Giulio Baldi, European Journal of Cancer MedicineSurgical PathologyClinical EvidencePathologyOncology	2014	66
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour Silvia Stacchiotti, Maristella Saponara, Roberta Frapolli, European Journal of Cancer Tumor BiologyOncologyHigh SensitivityMedicineTheranostics	2017	37
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) Emanuela Palmerini, Marco Gambarotti, Antoîne Italiano, European Journal of Cancer MedicinePathologyGlobal Collaborative StudyOncologyRadiation Oncology	2023	37
Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series Luca Bergamaschi, Rossella Bertulli, Michela Casanova, Medical Oncology Surgical OncologyMedicineTreatment ModalitiesPathologyProspective Single-center Series	2019	30
Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution Andraž Perhavec, Salvatore Provenzano, Marco Baia, Annals of Surgical Oncology Surgical OncologyReasons Against ResectionMedicineSurgical PathologySurgery	2020	28
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma Vittoria Colia, Marco Fiore, Salvatore Provenzano, Clinical Sarcoma Research	2017	27

Page 1